Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial
- Resource Type
- Article
- Authors
- Chaganti, Sridhar; Maycock, Shanna; McIlroy, Graham; Jackson, Aimee; Bishop, Rebecca; Johnson, Sarah; Kanfer, Edward; Kassam, Shireen; Cwynarski, Kate; Wrench, David; Arumainathan, Arvind; Fox, Christopher P.; Johnson, Rod; McKay, Pam; Paneesha, Shankara; Rowntree, Clare; Balotis, Constantine; Collins, Graham P.; Davies, Andrew; Wright, Josh; Burns, Sarah; Laurence, Arian; Wheatley, Keith; Menne, Tobias
- Source
- In Blood 25 July 2024 144(4):392-401
- Subject
- Clinical Trials and Observations
Lymphoid Neoplasia
- Language
- ISSN
- 0006-4971